Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Stock, $0.0001 par value · CUSIP: 52886X107

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • D1 Capital Partners L.P.

    Shares: 978,652.00 · Class: 2.9%

  • Daniel Sundheim

    Shares: 978,652.00 · Class: 2.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002358
Form type
SCHEDULE 13G/A
Filer
D1 Capital Partners L.P.
CIK
CIK 1747057
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub